Litigation Details for Valeant Pharmaceuticals International, Inc. (S.D.N.Y. 2017)
✉ Email this page to a colleague
Valeant Pharmaceuticals International, Inc. (S.D.N.Y. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-08-28 |
| Court | District Court, S.D. New York | Date Terminated | 2017-11-30 |
| Cause | 18:1341 Patent Infringement | Assigned To | Paul Adam Engelmayer |
| Jury Demand | None | Referred To | |
| Patents | 8,247,425; 8,420,663; 8,552,025; 8,822,490; 9,180,125; 9,669,096 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Valeant Pharmaceuticals International, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Valeant Pharmaceuticals International, Inc. (S.D.N.Y. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-08-28 | 1 | infringement of U.S. Patent Nos. 8,247,425 (“the ’425 patent”); 8,420,663 (“the ’663 patent”); 8,552,025 (“…021964, the ’025 patent, the ’425 patent, the ’663 patent, the ’490 patent, the ’125 patent, and the ’096… of the ’425 patent, the ’663 patent, the ’025 patent, the ’490 patent, the ’125 patent, and the ’096… of the ’425 patent, the ’663 patent, the ’025 patent, the ’490 patent, the ’125 patent, and the ’096… of the ’425 patent, the ’663 patent, the ’025 patent, the ’490 patent, the ’125 patent, and the ’096 | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
